Angiotensin-converting enzyme insertion/deletion genotype is associated with the activities of plasma coagulation factor VII and X independent of triglyceride metabolism

Coronary Artery Disease

Volumn 14, Issue 4, 2003, Pages 285-291

  Okura, Yoshifumi ^a   Hayashi, Kozo ^b   Shingu, Tetsuji ^b   Kuga, Yoshio ^b   Nomura, Shuichi ^b   Kajiyama, Goro ^b   Nakashima, Yoshiyuki ^c   Saku, Keijiro ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^c FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

Angiotensin converting enzyme; Coagulation factor; Coronary artery disease; Polymorphism; Risk factors

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; DIPEPTIDYL CARBOXYPEPTIDASE; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ANAMNESIS; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HEART INFARCTION; HUMAN; JAPAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0042872469     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mca.0000072847.84236.34     Document Type: Article

References (44)

1. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, et al. Deletion polymorphism of the angiotensin-I converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994; 90:2199-2202.
2. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359:641-644.
3. Oike Y, Hata A, Ogata Y, Numata Y, Shido K, Kondo K. Angiotensin-converting enzyme as a genetic risk factor for coronary artery spasm. Implication in the pathogenesis of myocardial infarction. J Clin Invest 1995; 96:2975-2979.
4. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, et al. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330:1634-1638.
5. Marian AJ, Yu QT, Workman R, Greve G, Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993; 342:1065-1066.
6. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, et al. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993; 342:1073-1075.
7. Kario K, Matsuo T, Kobayashi H, Kanai N, Hoshide S, Mitsuhashi T, et al. Endothelial cell damage and angiotensin-converting enzyme insertion/deletion genotype in elderly hypertensive patients. J Am Coll Cardiol 1996; 32:444-450.
8. Wang XL, McCredie RM, Wilcken DE. Genotype distribution of angiotensin-converting enzyme polymorphism in Australian healthy and coronary populations and relevance to myocardial infarction and coronary artery disease. Arterioscler Thromb Vasc Biol 1996; 16:115-119.
9. Ludwig E, Corneli PS, Anderson JL, Marshall HW, Lalouel JM, Ward RH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995; 91:2120-2124.
10. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1966; 2:533-537.
11. Broadhurst P, Kelleher C, Hughes L, Imeson JD, Raftery EB. Fibrinogen, factor VII clotting activity, and coronary artery disease severity. Atherosclerosis 1990; 85:169-173.
12. Hoffman CJ, Miller RH, Lawson WE, Hultin MB. Elevation of factor VII activity and mass in young adults at risk of ischemic heart disease. J Am Coll Cardiol 1969; 14:941-946.
13. Meade TVV, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342:1076-1079.
14. Negri M, Arigliano PL, Talamini G, Carlini S, Manzato F, Bonadonna G. Levels of plasma factor VII and factor VII activated forms as a function of plasma triglyceride levels. Atherosclerosis 1993; 99:55-61.
15. Hoffman CJ, Lawson WE, Miller RH, Hultin MB. Correlation of vitamin K-dependent clotting factors with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb 1994; 14:1737-1740.
16. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51:S5-S40.
17. Friedewald WT, Levy RI, Fredrikson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
18. Ikeda T, Shibuya Y, Senda U, Sugiuchi H, Araki S, Uji Y, et al. Automated immunoturbidimetric analysis of six plasma apolipoproteins: correlation with radial immunodiffusion assays. J Clin Lab Ana 1991; 5:90-95.
19. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti B-100 and apo A-I immunoaffinity mixed gels. Clin Chim Acta 1993; 223:53-71.
20. Dati F, Barthels M, Conard J, Fluckiger J, Girolami A, Hanseler E, et al. Multicenter evaluation of a chromogenic substrate method for photometric determination of prothrombin time. Thromb Haemost 1967; 58:656-665.
21. Declerck PJ, Alessi MC, Verstreken M, Kruithof EK, Juhan-Vague I, Collen D. Measurement of plasminogen activator inhibitor-1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1966; 71:220-225.
22. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988; 16:1215.
23. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239:487-491.
24. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase-1). Nucl Acids Res 1992; 20:1433.
25. Higashimori K, Zhao Y, Higaki J, Kamitani A, Katsuya T, Nakura J, et al. Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Commun 1993; 191:399-404.
26. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Soubrier F. Evidence from combined segregation and linkage analysis that a variant of the angiotensin-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51:197-205.
27. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346.
28. Bohn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and parental history of myocardial infarction. Clin Genet 1993; 44:298-301.
29. Tiret L, Kee F, Poirier O, Nicaud V, Lecerf L, Evans A, et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993; 341:991-992.
30. Badenhop RF, Wang XL, Wilcken DE. Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation 1995; 91:1655-1658.
31. Moor E, Silveira A, van't Hooft F, Suontaka AM, Eriksson P, Blomback M, et al. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Arterioscler Thromb Vasc Biol 1995; 15:655-664.
32. Scarabin PY, Aillaud MF, Amouyel P, Evans A, Luc G, Ferrieres J, et al. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction-the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Thromb Haemost 1998; 80:749-756.
33. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of haemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997; 96:1102-1108.
34. Margaglione M, Cappucci G, d'Addedda M, Colaizzo D, Giuliani N, Vecchione G, et al. PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants. Arterioscler Thromb Vasc Biol 1998; 18:562-567.
35. Kim DK, Kim JW, Kim S, Gwon HC, Ryu JC, Huh JE, et al. Polymorphism of angiotensin-converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol 1997; 17:3242-3247.
36. Margaglione M, Grandone E, Vecchione G, Cappucci G, Giuliani N, Colaizzo D, et al. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiotensin-converting enzyme (ACE) genes. Arterioscler Thromb Vasc Biol 1997; 17:2082-2087.
37. Kerins DM, Hao Q, Vaughan DE. Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J Clin Invest 1995; 96:2515-2520.
38. Fuhrer G, Gallimore M J, Heller W, Hoffmeister HE. FXII. Blut 1990; 61:258-266.
39. Hoffmeister HM, Jur M, Wendel HP, Heller W, Seipel L. Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and post-acute phases in patients with unstable angina pectoris. Circulation 1995; 91:2520-2527.
40. Kelleher CC, Mitropoulos KA, Imeson J, Meade TW, Martin JC, Reeves BE, et al. Hageman factor and risk of myocardial infarction in middle-aged men. Atherosclerosis 1992; 97:67-73.
41. Mitropoulos KA, Miller GJ, Watts GF, Durrington PN. Lipolysis of triglyceriderich lipoproteins activates coagulant factor XII: a study in familial lipoprotein-lipase deficiency. Atherosclerosis 1992; 95:119-125.
42. Mitropoulos KA, Martin JC, Stirling Y, Morrisey JH, Cooper JA. Activation of factors XII and VII induced in citrated plasma in the presence of contact surface. Thromb Res 1995; 78:67-75.
43. Vaughan DE. Angiotensin and vascular fibrinolytic balance. Am J Hypertens 2002; 15:3S-8S.
44. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, et al. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994; 90:669-676.